Aucta Drug Patent Portfolio
Aucta owns 1 orange book drug protected by 3 US patents Given below is the list of Aucta's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11337943 | Lacosamide pharmaceutical composition and dosage form thereof | 05 Jun, 2040 | Active |
| US11883374 | Lacosamide pharmaceutical composition and dosage form thereof | 05 Jun, 2040 | Active |
| US12042474 | Lacosamide pharmaceutical composition and dosage form thereof | 05 Jun, 2040 | Active |
Latest Legal Activities on Aucta's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Aucta.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Recordation of Patent Grant Mailed
Critical
| 24 May, 2022 | US11337943 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 24 May, 2022 | US11337943 |
|
Email Notification
Critical
| 05 May, 2022 | US11337943 |
|
Issue Notification Mailed
Critical
| 04 May, 2022 | US11337943 |
|
Application Is Considered Ready for Issue
Critical
| 26 Apr, 2022 | US11337943 |
| Dispatch to FDC | 26 Apr, 2022 | US11337943 |
|
Issue Fee Payment Verified
Critical
| 25 Apr, 2022 | US11337943 |
|
Issue Fee Payment Received
Critical
| 25 Apr, 2022 | US11337943 |
| Mail Post Card | 03 Feb, 2022 | US11337943 |
|
Email Notification
Critical
| 26 Jan, 2022 | US11337943 |
|
Mail Notice of Allowance
Critical
| 26 Jan, 2022 | US11337943 |
|
Notice of Allowance Data Verification Completed
Critical
| 24 Jan, 2022 | US11337943 |
| Date Forwarded to Examiner | 21 Dec, 2021 | US11337943 |
| PILOT- Request for After Final Consideration Program | 14 Dec, 2021 | US11337943 |
| Response after Final Action | 14 Dec, 2021 | US11337943 |
Aucta's Family Patents
Aucta Drug List
Given below is the complete list of Aucta's drugs and the patents protecting them.
1. Motpoly Xr
Motpoly Xr is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11337943 | Lacosamide pharmaceutical composition and dosage form thereof |
05 Jun, 2040
(14 years from now)
| Active |
| US11883374 | Lacosamide pharmaceutical composition and dosage form thereof |
05 Jun, 2040
(14 years from now)
| Active |
| US12042474 | Lacosamide pharmaceutical composition and dosage form thereof |
05 Jun, 2040
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Motpoly Xr's drug page